Literature DB >> 23599076

Treatment of neural anosmia by topical application of basic fibroblast growth factor-gelatin hydrogel in the nasal cavity: an experimental study in mice.

Jumpei Nota1, Hirotaka Takahashi, Nobuhiro Hakuba, Naohito Hato, Kiyofumi Gyo.   

Abstract

IMPORTANCE: A new treatment of neural anosmia.
OBJECTIVE: To investigate the effects of basic fibroblast growth factor (bFGF)-gelatin hydrogel on recovery of neural anosmia in mice.
DESIGN: Anosmia was induced by intraperitoneal injection of 3-methylindole, 200 mg/kg. One week later, the animals underwent 1 of the following 3 procedures bilaterally: (1) group A: single-shot intranasal drip infusion of phosphate-buffered saline, (2) group B: single-shot intranasal drip infusion of bFGF, and (3) group C: placement of bFGF-gelatin hydrogel in the nasal cavity. The olfactory function of the animal was evaluated by the odor-detection test (ODT) 2 and 4 weeks later. Following the testing, the animal was killed, the thickness of the olfactory epithelium was measured, and the number of olfactory marker protein (OMP)-positive cells was counted.
SETTING: Research installation. PARTICIPANTS: Mice. INTERVENTION: The placement of bFGF-gelatin hydrogel in the nasal cavity. MAIN OUTCOMES AND MEASURES: An ODT, thickness of olfactory epithelium, the number of OMP-positive cells
RESULTS: The ODT proved that neural anosmia recovered in group C but not in groups A and B. Histologically, olfactory epithelium became thicker and the number of OMP-positive cells increased in group C, while such functional and histologic recovery was poor in groups A and B. These findings suggested that placement of bFGF-gelatin hydrogel in the nasal cavity was an efficient way to facilitate recovery of neural anosmia. CONCLUSIONS AND RELEVANCE: As a gelatin hydrogel degrades slowly in the body, bFGF is gradually released around the site of the lesion; thus, it constantly exerts its effects on neural regeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23599076     DOI: 10.1001/jamaoto.2013.92

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  6 in total

1.  Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis.

Authors:  Frederick Yoo; Zachary M Soler; Jennifer K Mulligan; Kristina A Storck; Jensine M Lamira; Whitney N Pasquini; Jonathan B Hill; Tegan E Noonan; Brandon J Washington; Rodney J Schlosser
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-23       Impact factor: 3.858

2.  Effect of intranasal administration of neurotrophic factors on regeneration of chemically degenerated olfactory epithelium in aging mice.

Authors:  Yuriko Fukuda; Sayaka Katsunuma; Atsuhiro Uranagase; Jumpei Nota; Ken-Ichi Nibu
Journal:  Neuroreport       Date:  2018-11-07       Impact factor: 1.837

3.  Combined VEGF/PDGF improves olfactory regeneration after unilateral bulbectomy in mice.

Authors:  Kate Beecher; Louise M Hafner; Jenny Ekberg; James A St John; Fatemeh Chehrehasa
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

Review 4.  Factors that modulate olfactory dysfunction.

Authors:  Kate Beecher; James A St John; Fatemeh Chehrehasa
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 5.  Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.

Authors:  Shin Hyuk Yoo; Hae-Won Kim; Jun Hee Lee
Journal:  J Tissue Eng       Date:  2022-03-23       Impact factor: 7.813

6.  Efficacy of Platelet-Rich Plasma as an Adjuvant Therapy to Endoscopic Sinus Surgery in Anosmia Patients with Sinonasal Polyposis: A Randomized Controlled Clinical Trial.

Authors:  Ali Goljanian Tabrizi; Mahboobe Asadi; Mehdi Mohammadi; Amirhosein Abedi Yekta; Mohammadreza Sohrabi
Journal:  Med J Islam Repub Iran       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.